Well, that was quite the bounce yesterday. The morning start off well especially given the lack of market moving news but then a grind higher turned into a run. I would look at the highs of July 27th and July 28th as key levels. Despite the great move, if we cannot break above those levels […]
May 12th Biotech Update
We had our breakout and run yesterday and while there is little follow through today, I suspect that we get a continuation. It appears that the breakout is happening but the confirmation still needs to occur. The final signal would be to test the old resistance level with a selloff and to rally off the […]
May 1st Biotech Update
We finally get two days in a row of the same move but unfortunately it is down. This is not completely surprising as it is completely reasonable that the sharp move higher in the market needs to pause and/or retrench a little. Of course, the tension and worry will be whether or not this is […]
CHFS – Can The COVID-19 Pandemic Become the Inflection Point?
A Reported Shortage of Dialysis Machines Puts a Focus on Aquadex. Aquadex Smartflow System is being used to remove excess fluid from patients being treated with fluid resuscitation as part of the treatment for COVID-19, and in some cases is helping to relieve the shortage of dialysis machines at a growing number of hospitals. A […]
April 16th Biotech Update
It is a week of indecision despite having thought it would be a week of decision. It happens I guess but we are whiplashing higher and lower but, honestly, if I ignored the larger macro context and just looked at the XBI the chart the past couple weeks, it seems clearly in an uptrend. We […]
April 2nd Biotech Update
So it has been interesting the past couple days in the market. There was a lot of buying to end March but I think most saw that as the 60/40 (stock/bond) funds rebalancing. In other words, the move in the markets with stocks crashing and bonds flying meant that the 60/40 funds needed to sell […]
March 31st Biotech Update
A decent amount to talk about (some good some not so good). Yesterday I talked a little about the potential for the bottom to be in and data from China is actually supportive of that thesis. The PMI both bounced back in March and were better than expected. To be fair, a positive PMI survey […]
March 30th Biotech Update
The market continues higher albeit at a slower pace. Clearly the epidemic is not getting any better so why is the market holding up relative well? First, it could simply be the dead cat bounce from oversold conditions. I suspect that most think that is the likely scenario and that is not necessarily wrong. Second, […]
